利多卡因碱治疗室性心律失常
利多卡因碱型
产品名称：利多卡因碱
CAS号：137-58-6
测定：99％
包装：25kg /桶
分子式：C14H23N2O
分子量：235.3447
einecs：205-302-8
熔点：66-69℃; Cdeg;C
溶解度乙醇：4mg / mL
外观：白色结晶粉末
利多卡因碱描述
利多卡因也是最重要的1b类抗心律失常药物;静脉注射用于治疗室性心律失常（用于急性心肌梗塞，地高辛中毒，心脏复律或心脏导管插入术），如果胺碘酮不可用或禁忌。除颤后应给予利多卡因，CPR和血管加压素已经启动。急性心肌梗死不再推荐常规预防性给药;这一措施的整体效益并不令人信服。
吸入利多卡因可用作外周作用的镇咳药（咳嗽抑制剂），以减少咳嗽反射。该应用可以作为必须插管的患者的安全和舒适措施来实现，因为它可以降低咳嗽的发生率和从麻醉出现时可能导致的气管损伤。
利多卡因以及乙醇，氨和乙酸也已经被证明是有效的治疗水母叮咬，既扰乱了受影响的区域，又防止了进一步的杀线虫出血。
利多卡因碱主要功能如下：
局部麻醉
2.治疗癫痫
3.治疗哮喘

Lidocaine Base for the treatment of ventricular arrhythmias
Lidocaine Base Profile
Product Name: Lidocaine Base
CAS Number: 137-58-6
Assays: 99%
Packaging: 25kg/drum
Molecular Formula: C14H23N2O
Molecular Weight: 235.3447
EINECS: 205-302-8
Melting point :66-69 °Cdeg;Cdeg;C
solubility ethanol: 4 mg/mL
Appearance: White crystaline powder
Lidocaine Base Description
Lidocaine is also the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.
Inhaled lidocaine can be used as an antitussive (cough suppressor) acting peripherally to reduce the cough reflex. This application can be implemented as a safety and comfort measure for patients who have to be intubated, as it reduces the incidence of coughing and any tracheal damage it might cause when emerging from anesthesia.
Lidocaine, along with ethanol, ammonia, and acetic acid, has also been proven to be effective in treating jellyfish stings, both numbing the affected area and preventing further nematocyst discharge.
Lidocaine Base Main functions are as follows:
1.Local anesthetic.
2. Treating Epilepsy.
3. Treating Asthma.